More serious but less common risks can include: Gallbladder disease Pancreatitis Worsening of diabetic retinopathy in patients with diabetes Thyroid C-cell tumors observed in animal studies Certain conditions, medications, or risk factors may influence whether a healthcare provider thinks GLP-1s are appropriate for you, so women should review their full medical history with a qualified provider before starting therapy
The most common side effects are gastrointestinalnausea, vomiting, diarrhea, constipation, and a sense of early fullnesslargely due to delayed gastric emptying and central appetite suppression
CrossRef Targeting endoplasmic reticulum stress-induced CLGN resensitizes hepatocellular carcinoma to apoptosis: paeonol synergistically enhances efficacy by dual inhibition of CLGN and NF-B Sitong Yan, Anqi Wang, Xiang Chen, Weijia Jiang, Xiao Du, Yuhan Huang, Xiangyu Zu, Yue Zhu, Jiatao Liu, Lulu Fan, Lingling Zhang, Guoping Sun Frontiers in Oncology .2025;[Epub] CrossRef Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs Xiangnan Feng, Dayong Li, Pingyu Wang, Xinyu Li, Guangyao Li Oncology Research .2025
Based on the trial profile, it may suit people who havent lost enough weight on GLP-1-based medications, or who need the largest possible weight loss for severe obesity-related conditions
